Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Daratumumab and Venetoclax-Containing Regimens in the Management of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Hematological Malignancies

Fan Yang, Zhihui Li, MD, Changwei Dong, MD, Yang LEI, MD, YanPing Geng, MD, XiaoPei Wen, MD, Yan Zhou, MD, Tong Wu, MD

Blood (2020) 136 (Supplement 1): 9.

https://doi.org/10.1182/blood-2020-141766

Published: 2020

Journal Articles

Interleukin-7 Receptor Gene Heterozygous Mutations in Recipients Significantly Increase Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Fan Yang, Yang LEI, MD, Qinlong Zheng, PhD, Caiyan Zhang, PhD, Yueqian Feng, MD, Changwei Dong, MD, Zhihui Li, Yongqiang Zhao, MD, Yanzhi Song, MD, Tong Wu, MD

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-140164

Published: 2020

Journal Articles

The Quick Antigen Identification By Tissue Flow Cytometry for CAR-T Therapy in Relapsed/Refractory B-Cell Malignancies without Bone Marrow Involvement or Serous Cavity Effusions

Xinjian Yu, Pan Li, Heyuan Feng, Jian Kang, Xichang Zheng, Yunmei Zhang, Wenhong Yang, Tong Wu, MD, Shuangyou Liu

Blood (2020) 136 (Supplement 1): 11–12.

https://doi.org/10.1182/blood-2020-139437

Published: 2020

Journal Articles

CD22 Gating for Flow Cytometric Analysis in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia after CD19 CAR-T Therapy

Xinjian Yu, Pan Li, Heyuan Feng, Jian Kang, Xichang Zheng, Yunmei Zhang, Wenhong Yang, Tong Wu, MD, Shuangyou Liu

Blood (2020) 136 (Supplement 1): 13.

https://doi.org/10.1182/blood-2020-139341

Published: 2020

Journal Articles

Reduced Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation of AML in CR and MDS-a Systematic Review and Meta-Analysis of Randomized Controlled Trials

Yanzhi Song, MD, Zhichao Yin, Erhui Yuan, Yajing Wang, Tong Wu, MD

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-134167

Published: 2020

Journal Articles

A Novel t(9;22;11) Translocation Variant Involving 11q23 in a Patient with Chronic Myeloid Leukemia

Lin Yuehui, MD, Qinglong Zheng, Tong Wu, MD, DAN LIU

Blood (2020) 136 (Supplement 1): 7.

https://doi.org/10.1182/blood-2020-138460

Published: 2020

Journal Articles

Influence of Inherited and Acquired Hematological and Immunological Gene Variants on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

Zhihui Li, Yongqiang Zhao, MD, Yanzhi Song, MD, Caiyan Zhang, PhD, Qinlong Zheng, PhD, Chunrong Tong, Tong Wu, MD

Blood (2020) 136 (Supplement 1): 46–47.

https://doi.org/10.1182/blood-2020-139220

Published: 2020

Journal Articles

Potential Influence of Hematological or Immunological Hereditary Predisposition Genes on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

Zhihui Li, Qinlong Zheng, Yongqiang Zhao, Yanzhi Song, Fan Yang, Min Jiang, Chunrong Tong, Tong Wu, MD

Blood (2019) 134 (Supplement_1): 2037.

https://doi.org/10.1182/blood-2019-126339

Published: 2019

Journal Articles

Leukemia Burden in Peripheral Blood Has Negative Impact on CD19-CART Cell Culture and Its Clinical Efficacy in Patients with Refractory or Relapsed B Cell Acute Lymphoblastic Leukemia

Biping Deng, BS, MD, Jing Pan, Shuangyou Liu, Yuehui Lin, Zhaoli Liu, Yunlong Chen, Xiaoming Qu, Yu 'e Zhang, Zhongxin Zhang, Xuansha Niu, Ming Ma, Tong Wu, MD, Alex Hong Chang, Chunrong Tong

Blood (2019) 134 (Supplement_1): 1957.

https://doi.org/10.1182/blood-2019-126695

Published: 2019

Journal Articles

Corticosteroids Do Not Influence the Efficacy and Kinetics of CAR-T Cells for B-Cell Acute Lymphoblastic Leukemia

Shuangyou Liu, Biping Deng, BS, MD, Jing PAN, Zhichao Yin, Yuehui Lin, Zhuojun Ling, Tong Wu, MD, Zhiyong Gao, Yanzhi Song, Yongqiang Zhao, Chunrong Tong

Blood (2019) 134 (Supplement_1): 228.

https://doi.org/10.1182/blood-2019-123051

Published: 2019

Journal Articles

Prostaglandin E2 Promotes Recovery of Thymus in Survivors of the Hematopoietic Acute Radiation Syndrome (H-ARS)

TONG WU, MD PhD, Artur Plett, PhD, Hui Lin Chua, PhD, Louis M. Pelus, PhD, Christie M. Orschell, PhD

Blood (2017) 130 (Supplement 1): 1008.

https://doi.org/10.1182/blood.V130.Suppl_1.1008.1008

Published: 2017

Journal Articles

Immunodeficiency Caused Byheterozygous RAG1 Gene Mutation in a Boy Manifested As Severe Granulomatous Diseases and Eosinophilia: A Case Report

Jing PAN, MD, Min Xiong, Jingjing Wang, Shan Wang, Zhuojun Ling, Jinlong Xu, Jiajia Duan, Gen Wang, Tong Wu, MD PhD, Chunrong Tong

Blood (2017) 130 (Supplement 1): 4828.

https://doi.org/10.1182/blood.V130.Suppl_1.4828.4828

Published: 2017

Journal Articles

Clinical Features and Outcome of 22 Leukemia Patients with TLS-ERG Fusion Gene

Jing Pan, MD, Tong Wu, MD, Jun-Fang Yang, MD, Jian-Ping Zhang, Yan-Li Zhao, Yang Zhang, MD, Hong-Xing Liu, MD, Chun-Rong Tong, MD

Blood (2016) 128 (22): 3985.

https://doi.org/10.1182/blood.V128.22.3985.3985

Published: 2016

Journal Articles

Immunotherapy with Autologous Anti-CD19 Chimeric Antigen Receptor T Cells Followed By Allogeneic Hematopoietic Stem Cell Transplantation Has Remarkably Improved Leukemia-Free Survival in Refractory/Relapsed B-Cell Acute Lymphoblastic Leukemia

Yan-Li Zhao, MD, Tong Wu, MD, De-Yan Liu, Jian-Ping Zhang, Zhi-Jie Wei, Yue Lu, Xing-Yu Cao, Min Xiong, Jia-Rui Zhou, Rui-Juan Sun, Shu-Quan Ji, Chun-Rong Tong, Dao-Pei Lu

Blood (2016) 128 (22): 829.

https://doi.org/10.1182/blood.V128.22.829.829

Published: 2016

Journal Articles

Safety and Efficacy of Low Dose CD19 Targeted Chimeric Antigen Receptor T (CAR-T) Cell Immunotherapy in 47 Cases with Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Biping Deng, MD, Alex Hongsheng Chang, Professor, Junfang Yang, MD, Jing Pan, MD, Xian Zhang, PhD, Yuehui Lin, MD, Yanan Wu, MD, Zhenling Deng, PhD, Peihua Lu, MD, Tong Wu, MD, Zhaoli Liu, Bachelor, Yu'e Zhang, Bachelor, Chunrong Tong, MD

Blood (2016) 128 (22): 649.

https://doi.org/10.1182/blood.V128.22.649.649

Published: 2016

Journal Articles

Impact of NCCN Risk Stratification and Minimal Residual Disease on Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia

Yue Lu, Tong Wu, MD, Yan-Li Zhao, Xing-Yu Cao, De-Yan Liu, Jian-Ping Zhang, Min Xiong, Jia-Rui Zhou, Rui-Juan Sun, Zhi-Jie Wei, Hui Wang, Tong Wang, Hong-Xing Liu, Dao-Pei Lu

Blood (2016) 128 (22): 2296.

https://doi.org/10.1182/blood.V128.22.2296.2296

Published: 2016

Journal Articles

Identification of a De Novo UNC13D L1000P Mutation in a Familial Hemophagocytic Lymphohistiocytosis Patient

Hongxing Liu, MD, Fang Wang, MD, Juan Zhu, MD, Hui Wang, MD, Ping Wu, MD, Wen Teng, Xu Han, Jianfeng Zhang, Ping Zhu, MD, Tong Wu, MD, Chunrong Tong, MD

Blood (2011) 118 (21): 4927.

https://doi.org/10.1182/blood.V118.21.4927.4927

Published: 2011

Journal Articles

Three Novel Clonal Non-Characteristic Chromosome Aberrations in Acute Myeloid Leukemia Resembling Acute Promyelocytic Leukemia

Hongxing Liu, MD, Wenjun Tian, MD, Fang Wang, MD, Juan Zhu, MD, Wen Teng, Hui Wang, MD, Tong Wang, MD, Ping Wu, MD, Ping Zhu, MD, Tong Wu, MD, Chunrong Tong, MD

Blood (2011) 118 (21): 4912.

https://doi.org/10.1182/blood.V118.21.4912.4912

Published: 2011

Journal Articles

Haploidentical Hematopoietic Stem Cell Transplantation of Sex-Matched Donor-Recipient Pair Has Survival Advantage: A Single-Center Study of 440 Cases

Tong Wu, MD, Yan-Li Zhao, MD, Jing-Bo Wang, MD, Xing-Yu Cao, MD, Yu-Ming Yin, MD, Yuan Sun, MD, Yue Lu, MD, Jia-Rui Zhou, MD, Yan-Qun Gao, MD, Wan-Ming Da, MD, Shu-Quan Ji, MD, Yao-Chen Zhang, MD, Dao-Pei Lu, MD

Blood (2010) 116 (21): 228.

https://doi.org/10.1182/blood.V116.21.228.228

Published: 2010

Journal Articles

Predictable Recurrence by Regular Monitoring Minimal Residual Disease with Flowcytometry In the Patients with Both AML and ALL: A Single-Center Study of 158 Cases.

Chunrong Tong, MD, Junfang Yang, MD, Yuehui Lin, MD, Xinhong Fei, MD, Jie Zhao, MD, Xian Zhang, MD, Jiangying Gu, MD, Tong Wu, MD, Dao-Pei Lu, MD, Hui Wang, MD

Blood (2010) 116 (21): 1661.

https://doi.org/10.1182/blood.V116.21.1661.1661

Published: 2010

NARROW

Daratumumab and Venetoclax-Containing Regimens in the Management of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Hematological Malignancies

Interleukin-7 Receptor Gene Heterozygous Mutations in Recipients Significantly Increase Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

The Quick Antigen Identification By Tissue Flow Cytometry for CAR-T Therapy in Relapsed/Refractory B-Cell Malignancies without Bone Marrow Involvement or Serous Cavity Effusions

CD22 Gating for Flow Cytometric Analysis in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia after CD19 CAR-T Therapy

Reduced Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation of AML in CR and MDS-a Systematic Review and Meta-Analysis of Randomized Controlled Trials

A Novel t(9;22;11) Translocation Variant Involving 11q23 in a Patient with Chronic Myeloid Leukemia

Influence of Inherited and Acquired Hematological and Immunological Gene Variants on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

Potential Influence of Hematological or Immunological Hereditary Predisposition Genes on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

Leukemia Burden in Peripheral Blood Has Negative Impact on CD19-CART Cell Culture and Its Clinical Efficacy in Patients with Refractory or Relapsed B Cell Acute Lymphoblastic Leukemia

Corticosteroids Do Not Influence the Efficacy and Kinetics of CAR-T Cells for B-Cell Acute Lymphoblastic Leukemia

Prostaglandin E2 Promotes Recovery of Thymus in Survivors of the Hematopoietic Acute Radiation Syndrome (H-ARS)

Immunodeficiency Caused Byheterozygous RAG1 Gene Mutation in a Boy Manifested As Severe Granulomatous Diseases and Eosinophilia: A Case Report

Clinical Features and Outcome of 22 Leukemia Patients with TLS-ERG Fusion Gene

Immunotherapy with Autologous Anti-CD19 Chimeric Antigen Receptor T Cells Followed By Allogeneic Hematopoietic Stem Cell Transplantation Has Remarkably Improved Leukemia-Free Survival in Refractory/Relapsed B-Cell Acute Lymphoblastic Leukemia

Safety and Efficacy of Low Dose CD19 Targeted Chimeric Antigen Receptor T (CAR-T) Cell Immunotherapy in 47 Cases with Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Impact of NCCN Risk Stratification and Minimal Residual Disease on Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia

Identification of a De Novo UNC13D L1000P Mutation in a Familial Hemophagocytic Lymphohistiocytosis Patient

Three Novel Clonal Non-Characteristic Chromosome Aberrations in Acute Myeloid Leukemia Resembling Acute Promyelocytic Leukemia

Haploidentical Hematopoietic Stem Cell Transplantation of Sex-Matched Donor-Recipient Pair Has Survival Advantage: A Single-Center Study of 440 Cases

Predictable Recurrence by Regular Monitoring Minimal Residual Disease with Flowcytometry In the Patients with Both AML and ALL: A Single-Center Study of 158 Cases.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only